tiprankstipranks
ALPS Group (ALPS)
NASDAQ:ALPS
US Market

ALPS Group (ALPS) Price & Analysis

17 Followers

ALPS Stock Chart & Stats

$1.00
$0.00(0.00%)
At close: 4:00 PM EST
$1.00
$0.00(0.00%)

ALPS Group News

ALPS FAQ

What was ALPS Group’s price range in the past 12 months?
ALPS Group lowest stock price was $0.56 and its highest was $15.00 in the past 12 months.
    What is ALPS Group’s market cap?
    ALPS Group’s market cap is $128.11M.
      When is ALPS Group’s upcoming earnings report date?
      The company’s upcoming earnings report date is not yet available.
      How were ALPS Group’s earnings last quarter?
      Currently, no data Available
      Is ALPS Group overvalued?
      According to Wall Street analysts ALPS Group’s price is currently Overvalued. Get more investment ideas with TipRanks Premium
        Does ALPS Group pay dividends?
        ALPS Group pays a N/A dividend of $0.032 which represents an annual dividend yield of N/A. See more information on ALPS Group dividends here
          What is ALPS Group’s EPS estimate?
          ALPS Group’s EPS estimate for its next earnings report is not yet available.
          How many shares outstanding does ALPS Group have?
          ALPS Group has 166,400,330 shares outstanding.
            What happened to ALPS Group’s price movement after its last earnings report?
            Currently, no data Available
            Which hedge fund is a major shareholder of ALPS Group?
            Currently, no hedge funds are holding shares in ALPS
            What is the TipRanks Smart Score and how is it calculated?
            Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology

              Company Description

              ALPS Group

              Alps Group Inc. operates as a comprehensive biotechnology firm, delivering a wide array of services ranging from groundbreaking research and development to direct medical care and health optimization initiatives, with a primary focus on cutting-edge therapeutic solutions. The organization is committed to cultivating a just and balanced healthcare system, ensuring broad availability of early detection, disease prevention, and individualized treatment approaches.
              Similar Stocks
              Company
              Price & Change
              Follow
              Four Leaf Acquisition Corporation Class A
              Quetta Acquisition Corp.

              Ownership Overview

              0.05%99.95%
              Insiders
              0.05% Other Institutional Investors
              99.95% Public Companies and
              Individual Investors

              Options Prices

              Currently, No data available
              ---
              Popular Stocks